to share acquisition of FKR in Malaysia. However, if compared to Q1/17, there is a significant change in the decrease of liabilities of 75.90 million baht because cash received from capital increase

per Share (Baht) 0.52 0.53 0.39 0.35 2.12 1.79 -15.38% Performance Report Better performance of Thai Economy in FY2018 pushed forward the market’s growth in every aspect, as well as growth of Thai

be a potential market in the future. For Medical Devices; There is still intense competition in both domestic and foreign markets. Market leaders use price strategies to gain market share. But the

-355.1 -5.0% Gross Profit 707.7 1,026.1 -318.4 -31.0% Gross Profit Margin (%) 9.5% 12.6% -3.1% SG&A expenses 459.9 440.4 19.5 4.4% Loss on exchange rate 0.0 35.4 -35.4 -100.0% EBIT before share of profit

decrease in retained earnings of THB 210 million accounted for the 2019 interim dividend approved by the Board of Directors at the amount of THB 1,952 million (THB 0.65 per share), offsetting with profit for

shares with a par value of Baht 100 per share, in order to enhance KTMS’s business potential. The Board of Directors approved a resolution to subscribe for the newly issued share, in the total of 148,626

in financing activities was THB 1,030mn mainly from proceeds from the increase in share capital of THB 2,040mn. However, this offset by a decrease in short-term as well as long-term loans from

million baht. Consequently, net profit in 2017 was down to 4,929 million baht, a decrease of 10.6% and 26.6% from 2016 and 2015 respectively. Earnings per share decreased to 3.95 baht in 2017, from 4.42

same period of last year in the same trend of its industries. Cost of Goods Sold In Q1.2018, the Company and its subsidiaries had cost of goods sold (COGS) THB 894.7 mn represents a decrease of COGS to

) Consolidated * 2018 2017 Increase / (Decrease) % Change Revenues from sales 666.36 387.35 279.01 103.38% Other revenues 6.76 1.21 5.54 458.11% Total revenues 673.12 388.56 284.55 73.23% Cost of sales 256.50